Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland von Kawalec, P

Volltext

Direct Costs Of Diabetes Mellitus In Poland von Kawalec, P

Volltext

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis von Kawalec, P., Holko, P., Moćko, P., Pilc, A.

Volltext

HPR44 Analysis of Anatomical Therapeutic Chemical (ATC) Classification and Therapeutic Area of Orphan Medicinal Products (OMP) vs Reimbursement for These Drugs in 11 European Count... von Jakubowski, S, Kawalec, P

Volltext

The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland von Mocko, P, Kawalec, P

Volltext

Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012 von Malinowski, K, Kawalec, P

Volltext

Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012 von Kawalec, P, Malinowski, K

Volltext

Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma: A Systematic Review and Indirect Comparison von Kawalec, P

Volltext

PCN4 - Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma: A Systematic Review and Indirect Comparison von Kawalec, P

Volltext

PCN3 - Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC) von Kawalec, P

Volltext

Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland von Kawalec, P

Volltext

PSY60 - Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland von Kawalec, P

Volltext

Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC) von Kawalec, P

Volltext

CO3 Minimal Residual Disease in Untreated, Physically Fit Chronic Lymphocytic Leukemia (CLL) Patients (Fit Subpopulation): Results of a Systematic Review With Bayesian Network Meta... von Stożek-Tutro, A., Reczek, M, Kawalec, P

Volltext

CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia von Monica, M., Reczek, M., Kawalec, P.

Volltext

CO182 Efficacy of Venetoclax+Obinutuzumab+Ibrutinib Compared to Alternative Therapeutic Options in the First-Line Treatment of Chronic Lymphocytic Leukemia (Fit Population): A Syst... von Stożek-Tutro, A., Reczek, M., Kawalec, P.

Volltext

Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries von Kawalec, P

Volltext

PSY114 - Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries von Kawalec, P

Volltext

CO72 Risk of Richter Transformation in Relapsed/Refractory Cll: Results of Bayesian Network Meta-Analysis von Monica, M., Reczek, M., Kawalec, P.

Volltext

CO112 Efficacy and Safety of Venetoclax+Rituximab in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of Bayesian Network Meta-Analysis von Monica, M., Reczek, M., Kawalec, P.

Volltext